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Abstract
Introduction: Soluble (effervescent) paracetamol is routinely given to elderly patients for
convenience. A daily dose of 4 gm in this soluble formulation can contain up to 8.7 gm of sodium
chloride, which exceeds the threshold recommended by the World Health Organization.
Hypernatremia secondary to soluble paracetamol has rarely been reported. We describe an elderly
patient who developed hypernatremia shortly after taking soluble paracetamol.
Case presentation: A confused 89-year-old man with back pain secondary to metastatic prostatic
carcinoma was prescribed soluble paracetamol. Ten days later, his serum sodium concentration had
increased from 142 mmol/L to 165 mmol/L. Soluble paracetamol was withdrawn shortly before he
died, and was believed to have contributed to his hypernatremia.
Conclusion: Hypernatremia is associated with high morbidity and mortality. Clinicians should be
aware of the high sodium chloride content in soluble paracetamol, which can precipitate
hypernatremia in elderly patients with impaired renal function.
Introduction
Soluble (effervescent) paracetamol is routinely given to
elderly patients. A daily dose of 4 gm in this soluble
formulation can contain up to 8.7 gm of sodium chloride,
which exceeds the recommendations from the World
Health Organization (WHO). Hypernatremia secondary
to soluble paracetamol is rare. We describe an elderly
patient who developed hypernatremia shortly after taking
soluble paracetamol.
Case presentation
An 89-year-old Caucasian male, who was taking regular
paracetamol for chronic lower back pain, developed new
ailment. He was found to have prostatic carcinoma with
spinal metastases, and was given cyproterone acetate and
goserelin. His past medical history was significant only
for mild congestive heart failure. He was not taking other
medications. His serum sodium concentration was
142 mmol/L, urea 8.8 mmol/L, and serum creatinine
130 μmol/L. His creatinine clearance (Cockcroft-Gault
method) was 33 ml/min/70 kg and his estimated
glomerular filtration rate (eGFR) was 48 ml/min/1.73 m
2.
His oral intake had deteriorated on day 11. He was given
soluble paracetamol 1 gm four times daily for conve-
nience. Despite initial supplementation with maintenance
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subcutaneous infusion had to be provided, as intravenous
access became more difficult. By day 21, the serum sodium
concentration was 165 mmol/L, potassium 3.4 mmol/L,
urea 8.4 mmol/L, and creatinine 120 μmol/L were noted.
He had been normotensive, with positive fluid balance
and good urine output throughout his admission. When
hypernatremia was noted, dehydration was immediately
suspected to be the cause, and aggressive fluid resuscita-
tion was started. However, this failed to correct the
hypernatremia. After an online literature search, soluble
paracetamol was thought to be culpable. A suspension
formulation was substituted and the paracetamol was
withdrawn over the next 3 days.
His serum sodium concentration stabilisedat 161,159,and
160 mmol/L over these 3 days. By day 24, the paracetamol
had been stopped. He suffered severe clinical deterioration
through sepsis of unknown origin and worsening renal
function (urea 13.2 mmol/L, creatinine 165 μmol/L, eGFR
33 ml/min/1.73 m
2). He died on day 30.
Discussion
The temporal relation between soluble paracetamol
administration and the development of hypernatremia,
in the presence of stable renal function, suggests that our
patient may have incurred soluble paracetamol-induced
hypernatremia.
Elderly patients constitute a high percentage of the total
inpatient population. Renal function in older people
usually falls with increasing age, compromising the
handling of solutes and electrolytes by the kidneys [1].
Hypernatremia, defined as a serum sodium concentration
over 145 mmol/L, is associated with a high mortality in
elderly people (42-75%), especially when acquired acutely
in hospital [1-3]. Morbidity in survivors is high, with
neurological deficits if hypernatremia is severe. It is
therefore of paramount importance for health-care profes-
sionals to recognise, prevent, and treat the cause of
hypernatremia early.
High sodium intake has been an especial cause of concern
in the elderly, as chronic excess sodium intake has been
positively linked with hypertension and associated co-
morbidities. Current WHO guidelines stipulate that the
daily intake of sodium should not exceed 2 g, which is
equivalent to 5 gm of sodium chloride [4]. Considering
that a tablet of soluble paracetamol (Panadol) contains
18.6 mmol (427 mg) of sodium [5], 8 tablets of soluble
paracetamol a day will equate to 148.8 mmol (3.4 gm) of
sodium or 8.7 gm of salt, which exceeds WHO guidelines.
Soluble co-codamol (manufactured by Neolab) contains
19.1 mmol (438 mg) of sodium per tablet [5], which
corresponds to a maximum of 8.9 gm of sodium chloride
per day. Several frequently used over the counter medica-
tions, such as antacids and laxatives, also contain generous
amounts of sodium. For example, Alka Seltzer Effervescent
Antacid tablets contain 19.4 mmol (445 mg) of sodium
per tablet (maximum of 8 a day). Movicol, a commonly
used laxative, contains 8.1 mmol (187 mg) of sodium per
sachet [5]. A list of high sodium preparations has been
compiled by UK medicines information pharmacists and
is available on the National Electronic Library for
Medicines website [5].
Various cases of hypernatremia due to excessive oral
sodium consumption have been described. These include
cases due to co-codamol [6], sodium phosphate [7], and
soluble paracetamol [8]. There have also been reports of
hypertension in patients taking long-term soluble para-
cetamol [9]. Even after accounting for underreporting of
hypernatremia secondary to excessive sodium consump-
tion, such cases are rare. However, in all these cases
hypernatremia developed in patients with renal insuffi-
ciency, and several have been described in children. This
suggests that there are homoeostatic mechanisms for
maintaining serum sodium, which can be overcome
when renal handling of solute load is compromised. In
our patient, poor oral intake was a further contributory
factor.
Both health-care professionals and patients should be
aware of this pitfall. Care should be taken when
prescribing for patients in whom high sodium consump-
tion iscontraindicated, especiallythose withhypertension,
heart failure, hypernatremia, or renal insufficiency. More-
over, drug manufacturers should clearly communicate salt
concentrations to all parties concerned.
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